Exploiting Real-Time Genomic Surveillance Data To Assess 4CMenB Meningococcal Vaccine Performance in Scotland, 2015 to 2022
Journal article published in 2023 by
Charlene M. C. Rodrigues 
,
L. MacDonald ,
R. Ure,
A. Smith,
J. C. Cameron,
Martin C. J. Maiden
,
L. MacDonald ,
R. Ure,
A. Smith,
J. C. Cameron,
Martin C. J. Maiden
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
This study demonstrates the value of postimplementation genomic surveillance of vaccine-preventable pathogens in providing information on real-world vaccine performance. The data are consistent with 2 and 3 doses of Bexsero, delivered according to schedule, providing good protection against invasive disease caused by meningococci deduced from genomic data to be vaccine preventable.